ARN No Codificante Terapéutico, Microproteínas y Estrés Integrado en Cáncer
NONCOD
Hospital Universitario de Donostia
San Sebastián, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Donostia (4)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
2022
-
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
Journal for immunotherapy of cancer, Vol. 10, Núm. 11
2020
-
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
Liver International, Vol. 40, Núm. 7, pp. 1670-1685
2013
-
In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs
Human Mutation, Vol. 34, Núm. 10, pp. 1387-1395